PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF DA-3091 AFTER SUBCUTANEOUS INJECTION IN HEALTHY SUBJECTS.

被引：0
|
作者：
Rhee, S. [1 ]
Yi, S. [1 ]
Choi, Y. [1 ]
Jiang, F. [1 ]
Yoon, S. [1 ]
Cho, J. [1 ]
Yu, K. [1 ]
机构：
[1] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med & Hosp, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-115
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] COMPARATIVE PHARMACOKINETICS/PHARMACODYNAMICS AND SAFETY PROFILES AFTER SUBCUTANEOUS ADMINISTRATION OF DA3030 AND FILGRASTIM IN HEALTHY SUBJECTS.
    Kim, D.
    Yoo, B. W.
    Choi, C.
    Jang, J. Y.
    Cui, M.
    Kim, C. O.
    Park, M. S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S40 - S40
  • [2] Safety, tolerability, pharmacokinetics and pharmacodynamics of irbesartan after single and multiple doses in healthy male subjects.
    Marino, MR
    Langenbacher, KM
    Ford, NF
    Uderman, HD
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII53 - PII53
  • [3] Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects
    Yue-Qi Li
    Zheng-Yu Yan
    Hong-Wen Zhang
    Lu-Ning Sun
    Hui-Wen Jiao
    Mei-Feng Wang
    Li-Yuan Yu
    Lei Yu
    Zi-Qing-Yun Yuan
    Ling Meng
    Yong-Qing Wang
    [J]. European Journal of Clinical Pharmacology, 2017, 73 : 547 - 554
  • [4] Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects
    Li, Yue-Qi
    Yan, Zheng-Yu
    Zhang, Hong-Wen
    Sun, Lu-Ning
    Jiao, Hui-Wen
    Wang, Mei-Feng
    Yu, Li-Yuan
    Yu, Lei
    Yuan, Zi-Qing-Yun
    Meng, Ling
    Wang, Yong-Qing
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (05) : 547 - 554
  • [5] Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single, weekly, and TIW subcutaneous doses in healthy subjects.
    Cheung, WK
    Wacholtz, M
    Johnson, RW
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 228 - 228
  • [6] Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects.
    Vachharajani, N
    Shyu, W
    Stouffer, B
    Raymond, R
    Liao, W
    Tay, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 180 - 180
  • [7] EFFECTS OF DRONEDARONE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF LOSARTAN IN HEALTHY SUBJECTS.
    Bonnet, Denis
    Galleyrand, Jacques
    Brunet, Aurelie
    Sultan, Eric
    Gaud, Christine
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1080 - 1080
  • [8] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF INHALED REMDESIVIR IN HEALTHY SUBJECTS.
    Humeniuk, R.
    Juneja, K.
    Chen, S.
    Ellis, S.
    Xiao, D.
    Share, A.
    Johnston, M.
    Davies, S.
    Blair, C.
    Osinusi, A.
    Girish, S.
    Palaparthy, R.
    Dresser, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S26 - S26
  • [9] A CLINICAL STUDY TO ASSESS THE PHARMACOKINETICS AND PHARMACODYNAMICS OF TOCILIZUMAB AFTER A SINGLE DOSE ADMINISTRATION BY SUBCUTANEOUS AND INTRAVENOUS ROUTES TO HEALTHY SUBJECTS.
    Georgy, A.
    Zhang, X.
    Anzures-Cabrera, J.
    Foley-Comer, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S60 - S60
  • [10] PHARMACOKINETICS AND TOLERABILITY OF BALOXAVIR MARBOXIL AFTER A SINGLE ADMINISTRATION IN HEALTHY KOREAN SUBJECTS.
    Kim, B.
    Kim, Y.
    Lee, S.
    Yoon, D.
    Kim, Y.
    Lee, S.
    Jang, I.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S92 - S92
12345